# Post-Market Randomized Trial: Endoscopically- Guided Ablation vs. Radiofrequency Ablation

> **NCT01057394** · PHASE4 · TERMINATED · sponsor: **CardioFocus** · enrollment: 21 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** Endoscopically guided PVI Ablation
- **DEVICE:** RF PVI Ablation

## Key facts

- **NCT ID:** NCT01057394
- **Lead sponsor:** CardioFocus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Sponsor stopped study for business reasons; not for clinical or clinical outcomes reasons.
- **Last updated:** 2016-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057394, "Post-Market Randomized Trial: Endoscopically- Guided Ablation vs. Radiofrequency Ablation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01057394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*